StonvexLoading…
StonvexStonvexStonvexCore line items from IMMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $1.46B | $942.21M | $292.03M | $1.56B |
Operating Income | $18.69M | $13.70M | $-26.36M | $118.02M |
Net Income | $795.00K | $11.06M | $-930.00K | $64.28M |
EPS (Diluted) | $0.02 | $0.33 | $-0.03 | $1.90 |
Total Assets | $1.43B | $1.38B | $1.26B | $1.10B |
Total Liabilities | $870.72M | $803.24M | $715.62M | $543.58M |
Cash & Equivalents | $129.83M | $126.92M | $90.14M | $72.61M |
Free Cash Flow OCF − CapEx | $-36.56M | $931.00K | $-65.39M | $-68.81M |
Shares Outstanding | 33.06M | 32.88M | 32.82M | 32.50M |